Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
BMC Veterinary Research|April 9, 2025
Lumpy skin disease virus ORF142 protein inhibits type I interferon production by disrupting interactions of TBK1 and IRF3Zihan Chen, Jingyu Wang, Baochun Lu, et al.
Journal of Separation Science|September 11, 2014
On-chip protein isoelectric focusing using a photoimmobilized pH gradientLin Xia, FengMing Lin, Xin Wu, et al.
Journal of Clinical and Translational Hepatology|September 5, 2022
A K-nearest Neighbor Model to Predict Early Recurrence of Hepatocellular Carcinoma After ResectionChuanli Liu, Hongli Yang, Yuemin Feng, et al.
Frontiers in Veterinary Science|February 27, 2025
Efficacy and safety of anemoside B4 in canine pneumonia treatment: a prospective, randomized controlled trialJinzhao Ji, Xiaoqing Ding, Chuanli Liu, et al.
Digestive Diseases (Basel, Switzerland)|January 5, 2022
Increased Risk of Liver-Related Outcomes in Chronic Hepatitis B Patients with Metabolic Syndrome: A Systematic Review and Meta-AnalysisKhin Naing Thin, Andrew Tran, Jie Li, et al.
Cell Proliferation|April 23, 2023
Baffled-flow culture system enables the mass production of megakaryocytes from human embryonic stem cells by enhancing mitochondrial functionXumin Wu, Bowen Zhang, Keyi Chen, et al.
Biomaterials|December 29, 2022
Biomimetic Prussian blue nanozymes with enhanced bone marrow-targeting for treatment of radiation-induced hematopoietic injuryBowen Zhang, Gan Chen, Xumin Wu, et al.
Nature Communications|July 2, 2025
A rationally thin composite membrane with differentiated pore structure for industrial-scale alkaline water electrolysisJian You, Jinyu Lu, Chuanli Liu, et al.
Digestive Diseases (Basel, Switzerland)|February 3, 2021
NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South KoreaJiyoon Park, Eunice Yewon Lee, Jie Li, et al.
The Lancet. Gastroenterology & Hepatology|May 16, 2020
Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysisQing Ye, Biyao Zou, Yee Hui Yeo, et al.
Pageof 3